Lv1
50 积分 2022-10-14 加入
Uncommon de novo EGFRT790M-Mutant NSCLC characterized with unique genetic Features: Clinical response and acquired resistance to the third-generation EGFR-TKIs treatment
2个月前
已完结
Co-occurring EGFR p.E709X Mutation Mediates Primary Resistance to the Third-Generation EGFR-TKIs in EGFR p.G719X-Mutant Patients with Advanced NSCLC
2个月前
已完结
Genomic alterations in thyroid cancer: biological and clinical insights
2个月前
已完结
Molecular genetics and diagnosis of thyroid cancer
2个月前
已完结
The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020
2个月前
已完结
Efficacy and safety of KRAS G12C inhibitor IBI351 monotherapy in patients with advanced non-small cell lung cancer: results from a phase 2 pivotal study
5个月前
已完结
Morphological, immunophenotypical and molecular features of hypermutation in colorectal carcinomas with mutations in DNA polymerase ε (POLE)
8个月前
已完结
Expenditure and financial burden for common cancers in China: a hospital-based multicentre cross-sectional study
10个月前
已完结
The landscape of cancer research and cancer care in China
10个月前
已完结
Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C
1年前
已完结
皖公网安备34019202002308
